Cargando…

Recruiting to preclinical Alzheimer's disease clinical trials through registries

Participant registries are repositories of individuals who have expressed willingness to learn about studies for which they may be eligible. Registries are increasingly being used to improve recruitment to preclinical Alzheimer's disease (AD) clinical trials, which require large screening effor...

Descripción completa

Detalles Bibliográficos
Autor principal:	Grill, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399544/ https://www.ncbi.nlm.nih.gov/pubmed/28439532 http://dx.doi.org/10.1016/j.trci.2017.02.004

Ejemplares similares

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022)

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
por: Grill, Joshua D, et al.
Publicado: (2010)

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial
por: Raman, Rema, et al.
Publicado: (2021)

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials
por: Gold, Michael, et al.
Publicado: (2018)

Study partners should be required in preclinical Alzheimer’s disease trials
por: Grill, Joshua D., et al.
Publicado: (2017)

Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
por: Zhou, Yan, et al.
Publicado: (2016)

Measuring cognition and function in the preclinical stage of Alzheimer's disease
por: Weintraub, Sandra, et al.
Publicado: (2018)

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
por: Walter, S., et al.
Publicado: (2020)

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)

Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
por: Grill, Joshua D., et al.
Publicado: (2018)

Recruitment and retention of participant and study partner dyads in two multinational Alzheimer’s disease registration trials
por: Bernstein, Olivia M., et al.
Publicado: (2021)

Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials
por: Nuño, Michelle M., et al.
Publicado: (2019)

Biological sex differences in Alzheimer's preclinical research: A call to action
por: Waters, Ansley, et al.
Publicado: (2021)

Health disparities and clinical trial recruitment: Is there a duty to tweet?
por: Caplan, Arthur, et al.
Publicado: (2017)

The hidden variables problem in Alzheimer's disease clinical trial design
por: Liyanage, S. Imindu, et al.
Publicado: (2018)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023)

How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
por: Rao, Chinthalapally V., et al.
Publicado: (2021)

Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials
por: Grill, Joshua D, et al.
Publicado: (2015)

Recruiting the Immune System Against Disease: Lessons for Clinical and Systems Pharmacology
por: Vicini, Paolo, et al.
Publicado: (2019)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

Mobile and pervasive computing technologies and the future of Alzheimer’s clinical trials
por: Doraiswamy, P. Murali, et al.
Publicado: (2018)

Licensed Anti-Microbial Drugs Logical for Clinical Trials against Pathogens Currently Suspected in Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Alzheimer's disease in Down syndrome: An overlooked population for prevention trials
por: Strydom, André, et al.
Publicado: (2018)

Asian Americans and Pacific Islanders’ perspectives on participating in the CARE recruitment research registry for Alzheimer's disease and related dementias, aging, and caregiving research
por: Ta Park, Van, et al.
Publicado: (2021)

New challenges of geriatric cardiology: from clinical to preclinical research
por: Malavolta, Marco, et al.
Publicado: (2017)

The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials
por: Yarborough, Mark, et al.
Publicado: (2018)

Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy
por: Ryan, Mary M., et al.
Publicado: (2019)

Leaping the hurdles in developing regenerative treatments for the intervertebral disc from preclinical to clinical
por: Thorpe, Abbey A., et al.
Publicado: (2018)

Modeling Alzheimer’s disease: considerations for a better translational and replicable mouse model
por: Cho, Joshua D., et al.
Publicado: (2022)

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
por: Nobili, Annalisa, et al.
Publicado: (2022)

An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease
por: Xie, Qing, et al.
Publicado: (2019)

Building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rentz, Dorene M., et al.
Publicado: (2021)

Retinal Examination Modalities in the Early Detection of Alzheimer's Disease: Seeing Brain Through the Eye
por: Ma, Xiaoxi, et al.
Publicado: (2022)

Participant outcomes and preferences in Alzheimer's disease clinical trials: The electronic Person-Specific Outcome Measure (ePSOM) development program
por: Saunders, Stina, et al.
Publicado: (2018)

Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care
por: Gale, Seth A., et al.
Publicado: (2022)

Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
por: Sinyor, Benjamin, et al.
Publicado: (2021)

The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer’s disease and related dementias, aging, and caregiver-related research
por: Ta Park, Van M., et al.
Publicado: (2023)

The Economics of Reproducibility in Preclinical Research
por: Freedman, Leonard P., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_etqc33vveec8ppkbbjm0mhk0v7